Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn's disease: a case report.

Takeyama H, Mizushima T, Nakajima K, Uemura M, Haraguchi N, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M.

World J Surg Oncol. 2013 Nov 19;11:295. doi: 10.1186/1477-7819-11-295.

2.

C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.

Toiyama Y, Inoue Y, Saigusa S, Kawamura M, Kawamoto A, Okugawa Y, Hiro J, Tanaka K, Mohri Y, Kusunoki M.

Anticancer Res. 2013 Nov;33(11):5065-74.

PMID:
24222151
3.

Paraaortic lymph node metastasis showed CR to UFT/LV therapy in elderly rectal cancer.

Fujii S, Ota M, Ichikawa Y, Yamagishi S, Osada S, Suwa H, Kunisaki C, Ohki S, Endo I.

Hepatogastroenterology. 2010 May-Jun;57(99-100):472-6.

PMID:
20698211
4.

Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer.

Peng J, Xu Y, Guan Z, Zhu J, Wang M, Cai G, Sheng W, Cai S.

Ann Surg Oncol. 2008 Nov;15(11):3118-23. doi: 10.1245/s10434-008-0123-8. Epub 2008 Sep 3.

PMID:
18769971
5.

Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.

Uzcudun AE, Batlle JF, Velasco JC, Sánchez Santos ME, Carpeño Jde C, Grande AG, Juberías AM, Piñeiro EH, Olivar LM, García AG.

Dis Colon Rectum. 2002 Oct;45(10):1349-58.

PMID:
12394434
6.

Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.

Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Unno T, Kano A, Kuroyanagi H, Oya M, Yamaguchi T, Watanabe T, Muto T.

Ann Surg Oncol. 2014 Jan;21(1):189-96. doi: 10.1245/s10434-013-3216-y. Epub 2013 Aug 21.

PMID:
23963871
7.

Benefit of tegafur-uracil and leucovorin in chemoradiotherapy for rectal cancer.

Ishihara S, Hayama T, Yamada H, Nozawa K, Matsuda K, Watanabe T.

Hepatogastroenterology. 2011 May-Jun;58(107-108):756-62.

PMID:
21830385
8.
9.

The impact of preoperative chemoradiotherapy on advanced low rectal cancer.

Kao PS, Chang SC, Wang LW, Lee RC, Liang WY, Lin TC, Chen WS, Jiang JK, Yang SH, Wang HS, Lin JK.

J Surg Oncol. 2010 Dec 1;102(7):771-7. doi: 10.1002/jso.21711.

PMID:
20872811
10.

Inguinal lymph node metastases from rectal adenocarcinoma.

Luna-Pérez P, Corral P, Labastida S, Rodríguez-Coria D, Delgado S.

J Surg Oncol. 1999 Mar;70(3):177-80.

PMID:
10102348
11.

A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.

Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY.

Dis Colon Rectum. 2005 Jun;48(6):1161-8.

PMID:
15868237
12.

[A case of advanced rectal cancer responding to oral UFT and Leucovorin-based preoperative chemoradiation therapy].

Shibahara K, Hirazuka T, Yamamoto M, Ninomiya M, Mashino K, Fuji K, Ikeda T, Kahno T.

Gan To Kagaku Ryoho. 2006 Oct;33(10):1481-3. Japanese.

PMID:
17033242
13.

[A resected case of signet-ring cell carcinoma of the rectum].

Asukai K, Yoshioka S, Hata T, Mizumoto S, Noguchi K, Takiuchi D, Hamano R, Kashiwazaki M, Miki H, Tsujie M, Konishi M, Yano K.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2283-5. Japanese.

PMID:
23268051
14.

Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-Up.

Fernández-Martos C, Aparicio J, Bosch C, Torregrosa M, Campos JM, Garcera S, Vicent JM, Maestu I, Climent MA, Mengual JL, Tormo A, Hernandez A, Estevan R, Richart JM, Viciano V, Uribe N, Campos J, Puchades R, Arlandis F, Almenar D.

J Clin Oncol. 2004 Aug 1;22(15):3016-22. Epub 2004 Jun 21.

PMID:
15210740
15.

Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.

Leowardi C, Schneider ML, Hinz U, Harnoss JM, Tarantino I, Lasitschka F, Ulrich A, Büchler MW, Kadmon M.

Ann Surg Oncol. 2016 Mar;23(3):870-6. doi: 10.1245/s10434-015-4915-3. Epub 2015 Oct 14.

PMID:
26467453
16.

Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer.

Wang LW, Yang SH, Lin JK, Lin TC, Chan WK, Chen WS, Wang HS, Jiang JK, Lee RC, Li AF, Chao Y, Chi KH, Yen SH.

J Surg Oncol. 2005 Mar 15;89(4):256-63; discussion 263-4. Erratum in: J Surg Oncol. 2005 May 1;90(2):106.

PMID:
15726610
17.

[A case of synchronous multiple liver metastases of rectal cancer successfully treated with tegafur/uracil and oral leucovorin chemotherapy].

Ueda S, Minami Y, Hara Y, Kawano T, Tominaga T.

Gan To Kagaku Ryoho. 2011 Oct;38(10):1709-11. Japanese.

PMID:
21996973
18.

[Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].

Qiu MZ, Teng KY, Ruan DY, Li YH, Chen XQ, Pan ZZ, He YJ, Wan DS, Xu RH.

Ai Zheng. 2009 Jul;28(7):743-8. Chinese.

PMID:
19624903
19.

Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.

Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S; National Surgical Adjuvant Study of Colorectal Cancer.

Jpn J Clin Oncol. 2006 Apr;36(4):237-44. Epub 2006 May 4.

PMID:
16675478
20.

[A case of surgical approach to the recurrence of the para-aortic lymph nodes after resection of rectal cancer].

Fukunaga H, Ota H, Fujie Y, Shimizu K, Ogino T, Toyoda Y, Yoshioka A, Yoshioka S, Hojou S, Endo W, Kakutani A, Maeura Y.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2204-6. Japanese.

PMID:
20037371

Supplemental Content

Support Center